TOPORS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.599000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.053800E-01
Normal-vs-Stage2
2.434000E-01
Normal-vs-Stage3
2.346000E-02
Normal-vs-Stage4
7.962200E-01
Stage1-vs-Stage2
2.505800E-01
Stage1-vs-Stage3
1.659590E-02
Stage1-vs-Stage4
9.271200E-01
Stage2-vs-Stage3
1.08600017867388E-10
Stage2-vs-Stage4
2.969200E-01
Stage3-vs-Stage4
6.636200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.462400E-01
Normal-vs-AfricanAmerican
6.335200E-01
Normal-vs-Asian
1.288580E-01
Caucasian-vs-AfricanAmerican
4.982200E-01
Caucasian-vs-Asian
3.556400E-01
AfricanAmerican-vs-Asian
3.163400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.628800E-01
Normal-vs-Female
2.698200E-01
Male-vs-Female
5.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.713800E-02
Normal-vs-Age(41-60Yrs)
3.975000E-01
Normal-vs-Age(61-80Yrs)
2.531200E-01
Normal-vs-Age(81-100Yrs)
6.040500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.406400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.658000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.979800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.527800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.933900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.543800E-02
Normal-vs-Daily Drinker
1.110990E-01
Normal-vs-Weekly Drinker
2.923800E-01
Normal-vs-Occasional Drinker
4.633000E-01
Normal-vs-Social Drinker
3.761000E-01
Non Drinker-vs-Daily Drinker
9.286600E-01
Non Drinker-vs-Weekly Drinker
1.038580E-01
Non Drinker-vs-Occasional Drinker
6.394200E-02
Non Drinker-vs-Social Drinker
2.238000E-02
Daily Drinker-vs-Weekly Drinker
2.545600E-01
Daily Drinker-vs-Occasional Drinker
1.226750E-01
Daily Drinker-vs-Social Drinker
1.045410E-01
Weekly Drinker-vs-Occasional Drinker
7.163000E-01
Weekly Drinker-vs-Social Drinker
6.696600E-01
Occasional Drinker-vs-Social Drinker
9.756600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.608210E-01
Normal-vs-Grade 2
1.091020E-01
Normal-vs-Grade 3
1.657970E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.973800E-01
Grade 1-vs-Grade 3
6.848800E-01
Grade 1-vs-Grade 4
1.608210E-01
Grade 2-vs-Grade 3
4.865400E-01
Grade 2-vs-Grade 4
1.091020E-01
Grade 3-vs-Grade 4
1.657970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.663770E-01
Normal-vs-NonDiabetic
1.764780E-01
Diabetic-vs-NonDiabetic
7.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.036600E-03
Normal-vs-NoPancreatitis
2.297800E-01
Pancreatitis-vs-NoPancreatitis
3.401400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.051400E-01
Normal-vs-N1
2.672000E-01
N0-vs-N1
9.831800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.752800E-01
Normal-vs-TP53-NonMutant
6.593800E-01
TP53-Mutant-vs-TP53-NonMutant
5.444400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
